GENVIP – Publications

Publications

Since 2007 GENVIP has published more than 430 publications

¿Dónde se esconde el virus respiratorio sincitial?

Martinón-Torres F, González-Barcala FJ

Pubmed Full article

Doi:

Arch Bronconeumol

Factor de impacto:

Q2

Doi:

YEAR-TO-YEAR VARIATION IN ATTACK RATES COULD RESULT IN UNDERPOWERED RESPIRATORY SYNCYTIAL VIRUS VACCINE EFFICACY TRIALS

Billard MN, Wildenbeest J, Bont LJ, Nair H, McCracken JP, Oude Rengerink K; RESCEU Investigators (Martinón-Torres F)

Pubmed Full article

Doi:

J Clin Epidemiol

Factor de impacto:

Q1

Doi:

COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE PREVENTION STRATEGIES: MATERNAL VACCINE VERSUS SEASONAL OR YEAR-ROUND MONOCLONAL ANTIBODY PROGRAM IN NORWEGIAN CHILDREN

Li X, Bilcke J, Vázquez Fernández L, Bont L, Willem L, Wisløff T, Jit M, Beutels P; REspiratory Syncytial virus Consortium in EUrope (RESCEU) Investigators. (martinón-Torres F)

Pubmed Full article

Doi:

J Infect Dis

Factor de impacto:

Q1

Doi:

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II TRIAL TO EXPLORE THE EFFECTS OF A GABAA-Α5 NAM (BASMISANIL) ON INTELLECTUAL DISABILITY ASSOCIATED WITH DOWN SYNDROME

Goeldner C, Kishnani PS, Skotko BG, Casero JL, Hipp JF, Derks M, Hernandez MC, Khwaja O, Lennon-Chrimes S, Noeldeke J, Pellicer S, Squassante L, Visootsak J, Wandel C, Fontoura P, d'Ardhuy XL; Clematis Study Group (Martinón-Torres F)

Pubmed Full article

Doi:

J Neurodev Disord

Factor de impacto:

Q2

Doi:

PERFORMANCE ASSESSMENT OF A RAPID MOLECULAR RESPIRATORY SYNCYTIAL VIRUS POINT-OF-CARE TEST: A PROSPECTIVE COMMUNITY STUDY IN OLDER ADULTS

Zuurbier RP, Korsten K, Verheij TJM, Butler C, Adriaenssens N, Coenen S, Gruselle O, Vantomme V, van Houten MA, Bont LJ, Wildenbeest JG; REspiratory Syncytial Virus Consortium in EUrope (RESCEU) Investigators. (Martinón-Torres F)

Pubmed Full article

Doi:

J Infect Dis

Factor de impacto:

Q1

Doi:

RAPID VIRAL TESTING AND ANTIBIOTIC PRESCRIPTION IN FEBRILE CHILDREN WITH RESPIRATORY SYMPTOMS VISITING EMERGENCY DEPARTMENTS IN EUROPE

Tan CD, Hagedoorn NN, Dewez JE, Borensztajn DM, von Both U, Carrol ED, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie IK, Martinon-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Strle F, Tsolia M, Vermont CL, Yeung S, Zachariasse JM, Zenz W, Zavadska D, Moll HA; PERFORM Consortium

Pubmed Full article

Doi:

Pediatr Infect Dis J

Factor de impacto:

Q4

Doi:

Pediatric vaccination against COVID-19 and despite COVID-19

Martinón-Torres F

Pubmed Full article

Doi:

An Pediatr (Engl Ed)

Factor de impacto:

Q4

Doi:

A SYSTEMATIC REVIEW OF EUROPEAN CLINICAL PRACTICE GUIDELINES FOR RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS

Reeves RM, van Wijhe M, Lehtonen T, Stona L, Teirlinck AC, Vazquez Fernandez L, Li Y, Osei-Yeboah R, Fischer TK, Heikkinen T, van Boven M, Bøås H, Donà D, Barbieri E, Campbell H; RESCEU Investigators. (Martinón-Torres F)

Pubmed Full article

Doi:

J Infect Dis

Factor de impacto:

Q1

Doi:

EQUITY IN VACCINATION POLICIES TO OVERCOME SOCIAL DEPRIVATION AS A RISK FACTOR FOR INVASIVE MENINGOCOCCAL DISEASE.

Taha MK, Martinon-Torres F, Köllges R, Bonanni P, Safadi MAP, Booy R, Smith V, Garcia S, Bekkat-Berkani R, Abitbol V

Pubmed Full article

Doi:

Expert Rev Vaccines

Factor de impacto:

Q2

Doi:

COVIDPHY: A TOOL FOR PHYLOGEOGRAPHIC ANALYSIS OF SARS-COV-2 VARIATION

Bello X, Pardo-Seco J, Gómez-Carballa A, Weissensteiner H, Martinón-Torres F, Salas A

Pubmed Full article

Doi:

Environ Res

Factor de impacto:

Q1

Doi:

ROUTINE INFANT VACCINATION OF PNEUMOCOCCAL CONJUGATE VACCINES HAS DECREASED PNEUMONIA ACROSS ALL AGE GROUPS IN NORTHERN SPAIN

I. Rivero-Calle, J. Pardo Seco, P. F. Raguindin, F. Alvez, J. Gómez-Rial, A. Salas, J. Martinón Sanchez and F. Martinón-Torres

Hum Vaccine Immunother

Factor de impacto:

Q2

Doi:

Pubmed Full article

QUADRIVALENT INFLUENZA VACCINE PREVENTS ILLNESS AND REDUCES HEALTHCARE UTILIZATION ACROSS DIVERSE GEOGRAPHIC REGIONS DURING FIVE INFLUENZA SEASONS. A RANDOMIZED CLINICAL TRIAL

Ghassan Dbaibo, Arshad Amanullah, Carine Claeys, Allen Izu, Varsha K. Jain, Pope Kosalaraksa, Luis Rivera, Jyoti Soni, Emad Yanni, Khalequ Zaman, Beatriz Acosta, Miguel Ariza, Maria L. Arroba Basanta, Ashish Bavdekar, Alfonso Carmona, Luis Cousin, Jasur Danier, Alfonso Diaz, Javier Diez-Domingo, Ener C. Dinleyici, Saul N. Faust, Jose Garcia-Sicilia, Grace D. Gomez-Go, Maria L. A. Gonzales, Mustafa Hacimustafaoglu, Stephen M. Hughes, Teresa Jackowska, Shashi Kant, Marilla Lucero, Josep Mares Bermudez, Federico Martinón-Torres, May Montellano, Roman Prymula, Thanyawee Puthanakit, Renata Ruzkova, Iwona Sadowska-Krawczenko Henryk Szymanski, Angels Ulied, Wayne Woo, Anne Schuind and Bruce L. Innis for the Flu4VEC Study Group

Pediatr Infect Dis J

Factor de impacto:

Doi:

Pubmed Full article

GENVIP is a research group dedicated to the study of infectious diseases and the development of vaccines using Omics tools.

The team is based in Santiago de Compostela, a historic World Heritage city with great cultural wealth and a long-established university tradition. The research group is part of the Health Research Institute of Santiago de Compostela [Instituto de Investigación Sanitaria de Santiago (IDIS)], an institution that brings together the strengths of the University of Santiago and the University Clinical Hospital of Santiago de Compostela.

Covid-19; parallel sequencing; NGS; exomes; whole-genome sequencing; gene expression; RNAseq; nanostring; proteomics; proteomics